DEPRESSN 6 BIOTYPES X DMHC

 A

The 2024 study led by researchers at Stanford Medicine identifies six distinct "biotypes" of depression and anxiety based on functional MRI (fMRI) imaging of brain circuits.

By mapping how these circuits communicate—either being "overactive" (hyperconnectivity) or "sluggish" (hypoconnectivity)—doctors can predict which patients will respond to antidepressants or therapy.

The 6 Depression Biotypes

Biotype	Key Circuit Affected	Brain Activity Pattern	Primary Symptoms & Characteristics
DC+SC+AC+	Default Mode, Salience, & Attention	Hyperconnectivity (Overactive)	High levels of rumination (dwelling on negative thoughts), slower behavioral responses, and cognitive errors.
AC−	Attention Circuit	Hypoconnectivity (Underactive)	Difficulty with sustained concentration and focus; less severe tension but more errors on attention-based tasks.
NSA+PA+	Negative & Positive Affect	Hyperactivation to stimuli	Characterized by severe anhedonia (inability to feel pleasure) and intense ruminative brooding.
CA+	Cognitive Control	Hyperactivation	High levels of negative bias and threat dysregulation; patients struggle with executive function (planning/decision making).
NTCC−CA−	Negative Affect & Cognitive Control	Reduced connectivity/activity	Linked to less rumination than other types, but involves significant loss of functional connectivity during emotion processing.
DXSXAXNXPXCX	Multiple Circuits	No prominent circuit dysfunction	Symptoms exist without a single dominant circuit outlier; patients in this group often show slower reaction times to implicit threats.

---

Why This Matters for Treatment

The study found that specific types respond dramatically better to different treatments:

• CA+ Biotype: Responded best to the antidepressant venlafaxine.

• DC+SC+AC+ Biotype: Showed better results with behavioral talk therapy (specifically I-CARE).

• AC− Biotype: Showed the worst response to behavioral therapy, suggesting they may need pharmacological intervention first to stabilize focus.